Tumour necrosis factor, interleukin-6 and interleukin-10 are possibly involved in Plasmodium vivax-associated thrombocytopaenia in southern Pakistani population

详细信息    查看全文

• 作者：Afsheen Raza (7)
  Muhammad Shahzeb Khan (8)
  Najia Karim Ghanchi (7)
  Ahmed Raheem (7)
  Mohammad A Beg (7)
  
  7. Department of Pathology and Microbiology ; Aga Khan University ; Stadium Road ; PO Box 3500 ; Karachi ; 74800 ; Pakistan
  8. Dow University of Health Sciences ; Civil Hospital ; Karachi ; 74800 ; Pakistan
  
• 关键词：Plasmodium vivax ; Thrombocytopaenia ; Cytokines
• 刊名：Malaria Journal
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：13
• 期：1
• 全文大小：298 KB
• 参考文献：World Malaria Report 2011. World Health Organization, Geneva
  1. Lacerda, MV, Mourao, MP, Coelho, HC, Santos, JB (2011) Thrombocytopenia in malaria: who cares?. Mem Inst Oswaldo Cruz 106 Suppl 1: pp. 52-63 CrossRef
  2. Casals-Pascual, CKO, Newton, CR, Peshu, N, Roberts, DJ (2006) Thrombocytopenia in falciparum malaria is associated with high concentrations of IL-10. Am J Trop Med Hyg 75: pp. 434-436
  3. Echeverri, M, Tobon, A, Alvarez, G, Carmona, J, Blair, S (2003) Clinical and laboratory findings of Plasmodium vivax malaria in Colombia, 2001. Rev Inst Med Trop Sao Paulo 45: pp. 29-34 CrossRef
  4. Gonz谩lez, BRH, De Donato, M, Berrizbeitia, M, G贸mez, C, Gonz谩lez, L (2009) Hematologic variations in patient with malaria caused by Plasmodium vivax before, during and after treatment. Invest Clin 50: pp. 187-201
  5. Jadhav, UM, Patkar, VS, Kadam, NN (2004) Thrombocytopenia in malaria鈥揷orrelation with type and severity of malaria. J Assoc Physicians India 52: pp. 615-618
  6. Ladhani, S, Lowe, B, Cole, AO, Kowuondo, K, Newton, CR (2002) Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome. Br J Haematol 119: pp. 839-847 CrossRef
  7. Mohanty, D, Ghosh, K, Nandwani, SK, Shetty, S, Phillips, C, Rizvi, S, Parmar, BD (1997) Fibrinolysis, inhibitors of blood coagulation, and monocyte derived coagulant activity in acute malaria. Am J Hematol 54: pp. 23-29 CrossRef
  8. Mohapatra, MK, Padhiary, KN, Mishra, DP, Sethy, G (2002) Atypical manifestations of Plasmodium vivax malaria. Indian J Malariol 39: pp. 18-25
  9. Rasheed, ASS, Khan, SA (2009) Clinical and laboratory findings in acute malaria caused by various plasmodium species. J Pak Med Assoc 59: pp. 220-223
  10. Shaikh, QH, Ahmad, SM, Abbasi, A, Malik, SA, Sahito, AA, Munir, SM (2009) Thrombocytopenia in malaria. J Coll Physicians Surg Pak 19: pp. 708-710
  11. Srivastava, S, Ahmad, S, Shirazi, N, Kumar Verma, S, Puri, P (2011) Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand. Acta Trop 117: pp. 82-85 CrossRef
  12. Taylor, WR, Widjaja, H, Basri, H, Ohrt, C, Taufik, T, Tjitra, E, Baso, S, Fryauff, D, Hoffman, SL, Richie, TL (2008) Changes in the total leukocyte and platelet counts in Papuan and non Papuan adults from northeast Papua infected with acute Plasmodium vivax or uncomplicated Plasmodium falciparum malaria. Malar J 7: pp. 259 CrossRef
  13. Bhatia, V, Bhatia, J (2010) Severe thrombocytopenia with bleeding manifestations in two children secondary to Plasmodium vivax. Platelets 21: pp. 307-309 CrossRef
  14. Harish, R, Gupta, S (2009) Plasmodium vivax malaria presenting with severe thrombocytopenia, cerebral complications and hydrocephalus. Indian J Pediatr 76: pp. 551-552 CrossRef
  15. Lacerda, MV, Hipolito, JR, Passos, LN (2008) Chronic Plasmodium vivax infection in a patient with splenomegaly and severe thrombocytopenia. Rev Soc Bras Med Trop 41: pp. 522-523
  16. Lacerda, MVAM, Santos, PD, Arcanjo, AR, Alecrim, WD, Alecrim, MGC (2004) Idiopathic thrombocytopenic purpura due to vivax malaria in the Brazilian Amazon. Acta Trop 90: pp. 187-190 CrossRef
  17. Parakh, A, Agarwal, N, Aggarwal, A, Aneja, A (2009) Plasmodium vivax malaria in children: uncommon manifestations. Ann Trop Paediatr 29: pp. 253-256 CrossRef
  18. Song, JY, Park, CW, Jo, YM, Kim, JY, Kim, JH, Yoon, HJ, Kim, CH, Lim, CS, Cheong, HJ, Kim, WJ (2007) Two cases of Plasmodium vivax Malaria with the clinical picture resembling toxic shock. Am J Trop Med Hyg 77: pp. 609-611
  19. Thapa, R, Biswas, B, Mallick, D, Sardar, S, Modak, S (2009) Childhood Plasmodium vivax malaria with severe thrombocytopenia and bleeding manifestations. J Pediatr Hematol Oncol 31: pp. 758-759 CrossRef
  20. Yamaguchi, S, Kubota, T, Yamagishi, T, Okamoto, K, Izumi, T, Takada, M, Kanou, S, Suzuki, M, Tsuchiya, J, Naruse, T (1997) Severe thrombocytopenia suggesting immunological mechanisms in two cases of vivax malaria. Am J Hematol 56: pp. 183-186 CrossRef
  21. D鈥橝cremont, V, Landry, P, Mueller, I, Pecoud, A, Genton, B (2002) Clinical and laboratory predictors of imported malaria in an outpatient setting: an aid to medical decision making in returning travelers with fever. Am J Trop Med Hyg 66: pp. 481-486
  22. Lathia, TBJR (2004) Can hematological parameters discriminate malaria from nonmalarious acute febrile illness in the tropics?. Indian J Med Sci 58: pp. 239-244
  23. Patel, U, Gandhi, G, Friedman, S, Niranjan, S (2004) Thrombocytopenia in malaria. J Natl Med Assoc 96: pp. 1212-1214
  24. Coelho, HCLS, Pimentel, JP, Nogueira, PA, Costa, FT, Siqueira, AM, Melo, GC, Monteiro, WM, Malheiro, A, Lacerda, MV (2006) Thrombocytopenia in Plasmodium vivax malaria is related to platelets phagocytosis. PLoS One 8: pp. e63410 CrossRef
  25. Grau, GE, Piguet, PF, Gretener, D, Vesin, C, Lambert, PH (1988) Immunopathology of thrombocytopenia in experimental malaria. Immunology 65: pp. 501-506
  26. Kaser, A, Brandacher, G, Steurer, W, Kaser, S, Offner, FA, Zoller, H, Theurl, I, Widder, W, Molnar, C, Ludwiczek, O, Atkins, MB, Mier, JW, Tilg, H (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98: pp. 2720-2725 CrossRef
  27. Wenisch, C, Linnau, KF, Looaresuwan, S, Rumpold, H (1999) Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria. J Infect Dis 179: pp. 747-750 CrossRef
  28. Williams, JR (2008) The Declaration of Helsinki and public health. Bull World Health Organ 86: pp. 650-652 CrossRef
  29. Warhurst, DC, Williams, JE (1996) Laboratory diagnosis of malaria. J Clin Pathol 49: pp. 533-538 CrossRef
  30. Snounou, GVS, Jarra, W, Thaithong, S, Brown, KN (1993) Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58: pp. 283-292 CrossRef
  31. Hussain, RKA, Shahid, F, Dojki, M, Jamil, B, Mehmood, H, Dawood, G, Dockrell, HM (2002) Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG vaccinated population. J Immunol Meth 264: pp. 95-108 CrossRef
  32. Park, JWPS, Yeom, JS, Huh, AJ, Cho, YK, Ahn, JY, Min, GS, Song, GY, Kim, YA, Ahn, SY, Woo, SY, Lee, BE, Ha, EH, Han, HS, Yoo, K, Seoh, JY (2003) Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without thrombocytopenia. Ann Trop Med Parasitol 97: pp. 339-344 CrossRef
  33. Angulo, I, Fresno, M (2002) Cytokines in the pathogenesis of and protection against malaria. Clin Diagn Lab Immunol 9: pp. 1145-1152
  34. Bridges, DJBJ, van Mourik, JA, Grau, G, Preston, RJ, Molyneux, M, Combes, V, O鈥橠onnell, JS, de Laat, B, Craig, A (2010) Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood 115: pp. 1472-1474 CrossRef
  35. Carvalho, BO, Lopes, SC, Nogueira, PA, Orlandi, PP, Bargieri, DY, Blanco, YC, Mamoni, R, Leite, JA, Rodrigues, MM, Soares, IS, Oliveira, TR, Wunderlich, G, Lacerda, MV, del Portillo, HA, Ara煤jo, MO, Russell, B, Suwanarusk, R, Snounou, G, R茅nia, L, Costa, FT (2010) On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis 202: pp. 638-647 CrossRef
  36. Raza, AGN, Sarwar Zubairi, AB, Raheem, A, Nizami, S, Beg, M (2013) Tumor necrosis factor -伪, interleukin-10, intercellular and vascular adhesion molecules are possible biomarkers of disease severity in complicated Plasmodium vivax isolates from Pakistan. PLoS One 8: pp. e81363 CrossRef
  37. Baatout, S (1996) Interleukin-6 and megakaryocytopoiesis: an update. Ann Hematol 73: pp. 157-162 CrossRef
  38. Hollen, CW, Henthorn, J, Koziol, JA, Burstein, SA (1992) Serum interleukin-6 levels in patients with thrombocytosis. Leuk Lymphoma 8: pp. 235-241 CrossRef
  39. Heits, F, Katschinski, DM, Wilmsen, U, Wiedemann, GJ, Jelkmann, W (1997) Serum thrombopoietin and interleukin 6 concentrations in tumour patients and response to chemotherapy-induced thrombocytopenia. Eur J Haematol 59: pp. 53-58 CrossRef
  40. Heits, F, Stahl, M, Ludwig, D, Stange, EF, Jelkmann, W (1999) Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J Interferon Cytokine Res 19: pp. 757-760 CrossRef
  41. Hollen, CW, Henthorn, J, Koziol, JA, Burstein, SA (1991) Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol 79: pp. 286-290 CrossRef
  42. D鈥橦ondt, VHY, Guillaume, T, Baatout, S, Chatelain, C, Berli猫re, M, Longueville, J, Feyens, AM, de Greve, J, Van Oosterom, A (1995) Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study. Blood 85: pp. 2347-2353
  43. Gordon, MS, Nemunaitis, J, Hoffman, R, Paquette, RL, Rosenfeld, C, Manfreda, S, Isaacs, R, Nimer, SD (1995) A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood 85: pp. 3066-3076
  44. Lazarus, HMWE, Williams, SF, Grinblatt, D, Campion, M, Cooper, BW, Gunn, H, Manfreda, S, Isaacs, RE (1995) Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer. Bone Marrow Transplant 15: pp. 935-942
  45. Schrezenmeier, H, Marsh, JC, Stromeyer, P, Muller, H, Heimpel, H, Gordon-Smith, EC, Raghavachar, A (1995) A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia. Br J Haematol 90: pp. 283-292 CrossRef
  46. van Gameren MM, WP, Mulder, NH, Limburg, PC, Groen, HJ, Vellenga, E, de Vries, EG (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 84: pp. 1434-1441
  47. Veldhuis, GJWP, Sleijfer, DT, van der Graaf, WT, Groen, HJ, Limburg, PC, Mulder, NH, de Vries, EG (1995) Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer. J Clin Oncol 13: pp. 2585-2593
  48. Weber, J, Yang, JC, Topalian, SL, Parkinson, DR, Schwartzentruber, DS, Ettinghausen, SE, Gunn, H, Mixon, A, Kim, H, Cole, D (1993) Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 11: pp. 499-506
  49. Sosman, JA, Verma, A, Moss, S, Sorokin, P, Blend, M, Bradlow, B, Chachlani, N, Cutler, D, Sabo, R, Nelson, M, Bruno, E, Gustin, D, Viana, M, Hoffman, R (2000) Interleukin 10-induced thrombocytopenia in normal healthy adult volunteers: evidence for decreased platelet production. Br J Haematol 111: pp. 104-111 CrossRef
  50. Maina, RN, Walsh, D, Gaddy, C, Hongo, G, Waitumbi, J, Otieno, L, Jones, D, Ogutu, BR (2010) Impact of Plasmodium falciparum infection on haematological parameters in children living in Western Kenya. Malar J 9 Suppl 3: pp. S4 CrossRef
  51. Saravu, K, Docherla, M, Vasudev, A, Shastry, BA (2011) Thrombocytopenia in vivax and falciparum malaria: an observational study of 131 patients in Karnataka, India. Ann Trop Med Parasitol 105: pp. 593-598 CrossRef
  
• 刊物主题：Parasitology; Infectious Diseases; Tropical Medicine;
• 出版者：BioMed Central
• ISSN：1475-2875

文摘

Background In Pakistan, Plasmodium vivax is endemic causing approximately 70% of the malaria cases. A number of haematological changes, especially thrombocytopaenia have been reported for P. vivax. Several host factors including cell-mediated immune cells, such as IL-1, IL-6 and IL-10 have been documented for P. vivax-induced thrombocytopaenia. However, study on correlation of cytokines and thrombocytopaenia in P. vivax, particularly in patients with severe signs and symptoms has not been reported from Pakistan. Methods A case control study to correlate TNF, IL-6 and IL-10 in healthy controls and thrombocytopaenic P. vivax-infected patients (both uncomplicated and complicated cases) from southern Pakistan was carried out during January 2009 to December 2011. One Hundred and eighty two patients presenting with microscopy-confirmed asexual P. vivax mono-infection and 100 healthy controls were enrolled in the study at Aga Khan University Hospital, Karachi. Enzyme-linked immunosorbent assay (ELISA) was performed for determination of TNF, IL-6 and IL-10 levels. Results Out of 182 cases, mild thrombocytopaenia (platelet count 100,000-150,000 mm3) was observed in ten (5.5%), moderate (50,000-100,000 mm3) in 93 (51.1%), and profound thrombocytopaenia (3) was detected in 79 (43.4%) patients. IL-6 and IL-10 levels were found approximately three-fold higher in the mild cases compared to healthy controls. Two-fold increase in TNF and IL-10 (p Conclusion Cytokines may have a possible role in P. vivax-induced thrombocytopaenia in Pakistani population. Findings from this study give first insight from Pakistan on the role of cytokines in P.vivax-associated thrombocytopaenia. However, further studies are required to understand the relevance of cytokines in manifestations of thrombocytopaenia in P. vivax malaria.